Molecular Aging Initiative to Profile Clonal Hematopoiesis Consequences in Patient Populations Published on Sep 03, 2019  Hereditary Cancer Risk Variants Found in Significant Subset of Metastatic Breast Cancer Patients Published on Aug 30, 2019

Live Webinar: Biomarker Evaluation for CAR T-Cell Therapy: Impact on Drug Development Adrian Bot, VP of Translational Medicine at Kite, a Gilead Company, will explain how biomarker evaluation for CAR T-cell therapy can elucidate the mechanism of action and impact drug development. Register Here